# Ultralow Dose PET Imaging of 18F-FDG Uptake

> **NCT06956391** · PHASE2 · RECRUITING · sponsor: **Akiva Mintz** · enrollment: 200 (estimated)

## Conditions studied

- Healthy Volunteer
- Cancer

## Interventions

- **DRUG:** 18F-FDG

## Key facts

- **NCT ID:** NCT06956391
- **Lead sponsor:** Akiva Mintz
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-05-12
- **Primary completion:** 2030-06-30
- **Final completion:** 2030-06-30
- **Target enrollment:** 200 (ESTIMATED)
- **Last updated:** 2025-06-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06956391

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06956391, "Ultralow Dose PET Imaging of 18F-FDG Uptake". Retrieved via AI Analytics 2026-06-12 from https://api.ai-analytics.org/clinical/NCT06956391. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*